DE69907951D1 - Verbesserungen in bezug auf pulver - Google Patents
Verbesserungen in bezug auf pulverInfo
- Publication number
- DE69907951D1 DE69907951D1 DE69907951T DE69907951T DE69907951D1 DE 69907951 D1 DE69907951 D1 DE 69907951D1 DE 69907951 T DE69907951 T DE 69907951T DE 69907951 T DE69907951 T DE 69907951T DE 69907951 D1 DE69907951 D1 DE 69907951D1
- Authority
- DE
- Germany
- Prior art keywords
- amino acid
- powder
- particles
- mum
- sup
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001413 amino acids Chemical class 0.000 abstract 4
- 239000002245 particle Substances 0.000 abstract 3
- 239000000843 powder Substances 0.000 abstract 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 239000011149 active material Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Glanulating (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Carbon And Carbon Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9827145 | 1998-12-09 | ||
| GBGB9827145.5A GB9827145D0 (en) | 1998-12-09 | 1998-12-09 | Improvements in or relating to powders |
| PCT/GB1999/004156 WO2000033811A2 (en) | 1998-12-09 | 1999-12-09 | Improvements in or relating to powders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69907951D1 true DE69907951D1 (de) | 2003-06-18 |
| DE69907951T2 DE69907951T2 (de) | 2004-03-11 |
Family
ID=10843948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69907951T Expired - Lifetime DE69907951T2 (de) | 1998-12-09 | 1999-12-09 | Verbesserungen in bezug auf pulver |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6989155B1 (de) |
| EP (1) | EP1137399B1 (de) |
| JP (1) | JP4410942B2 (de) |
| KR (1) | KR20010101138A (de) |
| CN (1) | CN1334723A (de) |
| AT (1) | ATE240093T1 (de) |
| AU (1) | AU770461B2 (de) |
| BR (1) | BR9916102A (de) |
| CA (1) | CA2353448C (de) |
| CZ (1) | CZ20012043A3 (de) |
| DE (1) | DE69907951T2 (de) |
| DK (1) | DK1137399T3 (de) |
| EA (1) | EA004045B1 (de) |
| ES (1) | ES2198973T3 (de) |
| GB (1) | GB9827145D0 (de) |
| HU (1) | HUP0104513A3 (de) |
| MX (1) | MXPA01005584A (de) |
| NO (1) | NO20012825L (de) |
| NZ (1) | NZ511965A (de) |
| PL (1) | PL348831A1 (de) |
| PT (1) | PT1137399E (de) |
| SK (1) | SK284775B6 (de) |
| TR (1) | TR200101591T2 (de) |
| WO (1) | WO2000033811A2 (de) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| EP2280004B1 (de) | 1999-06-29 | 2016-04-20 | MannKind Corporation | Pharmazeutische zusammensetzungen enthaltend insulin komplexiert mit diketopiperazin |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| JP2001151673A (ja) * | 1999-09-06 | 2001-06-05 | Nikken Chem Co Ltd | 吸入用粉末製剤の製造方法 |
| WO2002000197A1 (en) | 2000-06-27 | 2002-01-03 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| CA2413692C (en) * | 2000-06-27 | 2011-10-18 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| EP2168571B1 (de) | 2000-11-30 | 2018-08-22 | Vectura Limited | Inhalierbare Arzneizusammensetzung |
| AU2002222118A1 (en) † | 2000-11-30 | 2002-06-11 | Vectura Limited | Pharmaceutical compositions for inhalation |
| EP2283818B1 (de) | 2000-11-30 | 2017-08-02 | Vectura Limited | Herstellungsverfahren für Partikel zur Verwendung in einer Arrzneizusammensetzung |
| AU2002352836B2 (en) | 2001-11-20 | 2005-09-29 | Alkermes, Inc. | Improved particulate compositions for pulmonary delivery |
| US6923175B2 (en) | 2002-03-20 | 2005-08-02 | Mannkind Corporation | Inhalation apparatus |
| US20040009231A1 (en) * | 2002-03-20 | 2004-01-15 | Advanced Inhalation Research, Inc. | hGH (human growth hormone) formulations for pulmonary administration |
| CA2478974C (en) * | 2002-03-20 | 2014-12-16 | Advanced Inhalation Research, Inc. | Inhalable sustained therapeutic formulations |
| US7754242B2 (en) | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| US20110123574A1 (en) * | 2002-03-20 | 2011-05-26 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| US20060178394A1 (en) * | 2003-04-14 | 2006-08-10 | Staniforth John N | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| CN101010305B (zh) | 2004-08-20 | 2010-08-11 | 曼金德公司 | 二酮哌嗪合成的催化反应 |
| BR122019022692B1 (pt) | 2004-08-23 | 2023-01-10 | Mannkind Corporation | Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| NZ556709A (en) * | 2005-02-10 | 2009-09-25 | Glaxo Group Ltd | Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| US8062670B2 (en) * | 2005-08-05 | 2011-11-22 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
| KR101384456B1 (ko) | 2005-09-14 | 2014-04-10 | 맨카인드 코포레이션 | 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법 |
| GB0525254D0 (en) * | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| ES2647080T3 (es) * | 2006-02-22 | 2017-12-19 | Mannkind Corporation | Un método para mejorar las propiedades farmacéuticas de micropartículas que comprenden dicetopiperazina y un agente activo |
| DE102006030164A1 (de) * | 2006-06-29 | 2008-01-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Pulver |
| DE102006053375A1 (de) * | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mischung von Pulvern |
| US20090048155A1 (en) | 2007-08-15 | 2009-02-19 | Endacea, Inc. | Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| WO2011163272A1 (en) | 2010-06-21 | 2011-12-29 | Mannkind Corporation | Dry powder drug delivery system and methods |
| US8785396B2 (en) * | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| EP2222676A4 (de) | 2007-12-21 | 2011-10-26 | Endacea Inc | A1-adenosinrezeptorantagonisten |
| DK2293833T3 (en) | 2008-06-13 | 2016-05-23 | Mannkind Corp | DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| CA2728523C (en) | 2008-06-20 | 2020-03-10 | Mannkind Corporation | An interactive apparatus and method for real-time profiling of inhalation efforts |
| TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| DK2400950T3 (da) | 2009-02-26 | 2019-07-29 | Glaxo Group Ltd | Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
| CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| US8551528B2 (en) | 2009-06-12 | 2013-10-08 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| US9877967B2 (en) | 2010-01-26 | 2018-01-30 | Endacea, Inc. | Methods and pharmaceutical compositions for preventing and treating renal impairment |
| WO2012030647A1 (en) * | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| CN107096014B (zh) | 2010-09-29 | 2022-07-15 | 普马特里克斯营业公司 | 吸入用单价金属阳离子干粉剂 |
| AU2015249177B2 (en) * | 2010-11-09 | 2017-08-03 | Mannkind Corporation | Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines |
| ES2732818T3 (es) * | 2010-11-09 | 2019-11-26 | Mannkind Corp | Composición que comprende un agonista de receptores de serotonina y una dicetopiperazina para tratar migrañas |
| ES2625858T3 (es) | 2011-04-01 | 2017-07-20 | Mannkind Corporation | Paquete de tipo blíster para cartuchos farmacéuticos |
| RU2448717C1 (ru) * | 2011-04-20 | 2012-04-27 | Закрытое акционерное общество Научно-производственное предприятие "Тринита" | Способ получения антикоагулянтно-фибринолитического средства на основе гепарина |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| SI2739268T1 (sl) | 2011-08-01 | 2019-05-31 | Monash University | Postopek in formulacija za inhaliranje |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| CA3098386C (en) | 2012-07-12 | 2022-11-29 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| EP2911690A1 (de) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalierbare influenza-impfstoffzusammensetzungen und verfahren |
| WO2014106727A1 (en) | 2013-01-03 | 2014-07-10 | Vectura Limited | Inhaler and formulation |
| MX369136B (es) | 2013-03-15 | 2019-10-30 | Mannkind Corp | Composiciones de dicetopiperazina microcristalina y metodos. |
| WO2014165303A1 (en) | 2013-04-01 | 2014-10-09 | Pulmatrix, Inc. | Tiotropium dry powders |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
| WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| CN107106641B (zh) | 2014-10-31 | 2021-12-21 | 葛兰素史密斯克莱知识产权发展有限公司 | 粉末制剂 |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
| WO2017197051A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Amine-linked c3-glutarimide degronimers for target protein degradation |
| JP7057290B2 (ja) | 2016-06-27 | 2022-04-19 | アキリオン ファーマシューティカルズ，インコーポレーテッド | 医学的障害を治療するためのキナゾリン及びインドール化合物 |
| DK3985002T3 (da) | 2017-03-01 | 2025-08-18 | Achillion Pharmaceuticals Inc | Farmaceutiske aryl-, heteroaryl- og heterocyclylforbindelser til behandling af medicinske forstyrrelser |
| RU2770039C2 (ru) * | 2017-03-07 | 2022-04-14 | Филип Моррис Продактс С.А. | Вдыхаемые составы на основе никотина и способы их получения и применения |
| CN110769822A (zh) | 2017-06-20 | 2020-02-07 | C4医药公司 | 用于蛋白降解的n/o-连接的降解决定子和降解决定子体 |
| US20190177588A1 (en) * | 2017-12-12 | 2019-06-13 | Xotramorphic LLC | Compositions, Methods, and Systems For Producing Flocculent Materials for Special Effects |
| WO2019191112A1 (en) | 2018-03-26 | 2019-10-03 | C4 Therapeutics, Inc. | Cereblon binders for the degradation of ikaros |
| CN110441198A (zh) * | 2018-05-03 | 2019-11-12 | 人福普克药业（武汉）有限公司 | 一种检测尼达尼布软胶囊中尼达尼布粒径的方法 |
| JP7538113B2 (ja) | 2018-08-20 | 2024-08-21 | アキリオン ファーマシューティカルズ，インコーポレーテッド | 補体ｄ因子の医学的障害の治療のための医薬化合物 |
| CN113365617B (zh) | 2018-10-16 | 2025-12-23 | 乔治亚州立大学研究基金会股份有限公司 | 用于医学疾病治疗的一氧化碳前药 |
| EA202192738A1 (ru) | 2019-04-12 | 2022-03-17 | С4 Терапьютикс, Инк. | Трициклические соединения, обеспечивающие разрушение белка ikaros и белка aiolos |
| EP4603484A2 (de) | 2019-12-19 | 2025-08-20 | Georgia State University Research Foundation, Inc. | Verbindungen zum behandeln bakterieller infektionen und potenzierung von antibiotika |
| JP2023515073A (ja) | 2020-02-20 | 2023-04-12 | アキリオン ファーマシューティカルズ， インコーポレーテッド | 補体因子ｄ媒介障害の処置用のヘテロアリール化合物 |
| CN115279370B (zh) | 2020-03-05 | 2025-01-10 | C4医药公司 | 用于brd9的靶向降解的化合物 |
| JP7787164B2 (ja) | 2020-09-23 | 2025-12-16 | アキリオン ファーマシューティカルズ， インコーポレーテッド | 補体媒介性障害の治療のための医薬化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| EP0820277B1 (de) * | 1995-04-14 | 2005-01-26 | Nektar Therapeutics | Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit |
| GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| EP1666028B1 (de) * | 1999-10-29 | 2010-03-24 | Novartis AG | Trockenpulverzusammensetzungen mit verbesserter Dispersität |
-
1998
- 1998-12-09 GB GBGB9827145.5A patent/GB9827145D0/en not_active Ceased
-
1999
- 1999-12-09 NZ NZ511965A patent/NZ511965A/en not_active IP Right Cessation
- 1999-12-09 DK DK99958404T patent/DK1137399T3/da active
- 1999-12-09 EP EP99958404A patent/EP1137399B1/de not_active Expired - Lifetime
- 1999-12-09 PL PL99348831A patent/PL348831A1/xx not_active IP Right Cessation
- 1999-12-09 TR TR2001/01591T patent/TR200101591T2/xx unknown
- 1999-12-09 JP JP2000586305A patent/JP4410942B2/ja not_active Expired - Fee Related
- 1999-12-09 AT AT99958404T patent/ATE240093T1/de not_active IP Right Cessation
- 1999-12-09 CN CN99816052A patent/CN1334723A/zh active Pending
- 1999-12-09 KR KR1020017007067A patent/KR20010101138A/ko not_active Ceased
- 1999-12-09 CA CA2353448A patent/CA2353448C/en not_active Expired - Fee Related
- 1999-12-09 ES ES99958404T patent/ES2198973T3/es not_active Expired - Lifetime
- 1999-12-09 WO PCT/GB1999/004156 patent/WO2000033811A2/en not_active Ceased
- 1999-12-09 DE DE69907951T patent/DE69907951T2/de not_active Expired - Lifetime
- 1999-12-09 SK SK777-2001A patent/SK284775B6/sk unknown
- 1999-12-09 BR BR9916102-8A patent/BR9916102A/pt not_active Application Discontinuation
- 1999-12-09 US US09/857,392 patent/US6989155B1/en not_active Expired - Fee Related
- 1999-12-09 CZ CZ20012043A patent/CZ20012043A3/cs unknown
- 1999-12-09 EA EA200100636A patent/EA004045B1/ru not_active IP Right Cessation
- 1999-12-09 PT PT99958404T patent/PT1137399E/pt unknown
- 1999-12-09 HU HU0104513A patent/HUP0104513A3/hu unknown
- 1999-12-09 MX MXPA01005584A patent/MXPA01005584A/es unknown
- 1999-12-09 AU AU15777/00A patent/AU770461B2/en not_active Ceased
-
2001
- 2001-06-08 NO NO20012825A patent/NO20012825L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20012043A3 (cs) | 2001-12-12 |
| NO20012825D0 (no) | 2001-06-08 |
| CA2353448C (en) | 2010-02-23 |
| DK1137399T3 (da) | 2003-08-18 |
| AU1577700A (en) | 2000-06-26 |
| WO2000033811A2 (en) | 2000-06-15 |
| WO2000033811A3 (en) | 2000-10-12 |
| NO20012825L (no) | 2001-06-08 |
| NZ511965A (en) | 2003-09-26 |
| KR20010101138A (ko) | 2001-11-14 |
| SK284775B6 (sk) | 2005-11-03 |
| HUP0104513A2 (hu) | 2002-03-28 |
| EA200100636A1 (ru) | 2001-12-24 |
| TR200101591T2 (tr) | 2001-11-21 |
| AU770461B2 (en) | 2004-02-19 |
| JP2002531487A (ja) | 2002-09-24 |
| GB9827145D0 (en) | 1999-02-03 |
| HUP0104513A3 (en) | 2003-12-29 |
| BR9916102A (pt) | 2001-09-04 |
| CA2353448A1 (en) | 2000-06-15 |
| ATE240093T1 (de) | 2003-05-15 |
| MXPA01005584A (es) | 2003-07-14 |
| EP1137399A2 (de) | 2001-10-04 |
| DE69907951T2 (de) | 2004-03-11 |
| JP4410942B2 (ja) | 2010-02-10 |
| EP1137399B1 (de) | 2003-05-14 |
| EA004045B1 (ru) | 2003-12-25 |
| PL348831A1 (en) | 2002-06-17 |
| PT1137399E (pt) | 2003-09-30 |
| CN1334723A (zh) | 2002-02-06 |
| SK7772001A3 (en) | 2001-12-03 |
| US6989155B1 (en) | 2006-01-24 |
| ES2198973T3 (es) | 2004-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69907951D1 (de) | Verbesserungen in bezug auf pulver | |
| DE69942606D1 (de) | Aerosol-zusammensetzung | |
| CA2432175A1 (en) | Storage stable powder compositions of interleukin-4 receptor | |
| US8191802B2 (en) | Aerosol | |
| AU2003258706A1 (en) | Powder inhaler | |
| MX9707855A (es) | Administracion pulmonar de medicamentos en aerosol. | |
| AP1861A (en) | Dry powder inhalation system for transpulmonary administration | |
| TR200101442T2 (tr) | HFA 227 ve HFA 137 ihtiva eden farmasötik aeorosol bileşimi | |
| EP1312357A3 (de) | Pharmazeutische Formulierungen für Trockenpulverinhalatoren | |
| WO2003087335A3 (en) | Preservation of bioactive materials by spray drying | |
| CA2142355A1 (en) | Electrically conductive compositions of carbon particles and methods for their production | |
| MY132999A (en) | New formulation for inhalation | |
| WO2005025535A3 (en) | Methods for preparing pharmaceutical compositions | |
| NZ336592A (en) | Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising finely divided budesonide and a carrier | |
| MXPA03000321A (es) | Formulaciones de macrolido para inhalacion y metodos de tratamiento de infecciones endobronquiales. | |
| WO2001051026A3 (en) | Instant granules and process for their formulation | |
| CO4900027A1 (es) | Formulaciones en aerosol de furoato de mometasona sin cloro- fluorocarburos . | |
| PL355688A1 (en) | Antistatic powder coating compositions and their use | |
| DK1223972T3 (da) | Suspension af et EPI-hNE protein, fremgangsmåde til fremstilling deraf, tør pulveraerosol fremstillet deraf, farmaceutiske præparater indeholdende denne suspension eller aerosol samt anvendelser af disse | |
| WO2002043693A3 (en) | Pharmaceutical compositions for inhalation | |
| CA2413692A1 (en) | Method of making particles for use in a pharmaceutical composition | |
| AR007807A1 (es) | Polvo de aspartame para la aplicacion en mezclas de polvos y procedimiento para su preparacion | |
| MX2022015578A (es) | Composiciones en polvo de anatabina. | |
| HUT50858A (en) | Saving the environment aerosole composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: VECTURA LTD., CHIPPENHAM, WILTSHIRE, GB |